van Vulpen Jonna K, Eijkelenkamp Hidde, Grimbergen Guus, Wessels Frank J, Mulder Sasja F, Meijer Gert J, Intven Martijn P W
Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Phys Imaging Radiat Oncol. 2024 Nov 28;32:100683. doi: 10.1016/j.phro.2024.100683. eCollection 2024 Oct.
Stereotactic body radiation therapy (SBRT) may be a non-invasive strategy to treat patients with pancreatic oligometastases from renal cell carcinoma (RCC). We analyzed 11 patients treated with MR-guided SBRT to 31 pancreatic oligometastases. At a median follow-up of 31.6 months, 1-year and 2-year freedom from local progression was 100 % and 95 % (95 % CI 86-100 %), respectively. Moreover, 1-year and 2-year freedom from systemic therapy was 91 % (95 %CI 75-100 %) and 82 % (95 % CI 62-100 %), respectively. MR-guided SBRT may be a safe and effective treatment option for pancreatic oligometastases from RCC.
立体定向体部放射治疗（SBRT）可能是一种治疗肾细胞癌（RCC）胰腺寡转移患者的非侵入性策略。我们分析了11例接受磁共振引导下SBRT治疗31个胰腺寡转移灶的患者。中位随访31.6个月时，1年和2年局部无进展率分别为100%和95%（95%CI 86-100%）。此外，1年和2年无需全身治疗率分别为91%（95%CI 75-100%）和82%（95%CI 62-100%）。磁共振引导下SBRT可能是RCC胰腺寡转移的一种安全有效的治疗选择。
